IL2 and type 1 diabetes mellitus: Animal studies have demonstrated that bolstering the Treg compartment through adoptively transferring polyclonal or islet antigen-specific Tregs (13–16) or by administering low-dose IL-2 can prevent and reverse T1D (11, 17–19).